Keren Paz

Keren Paz

Company: Nectin Therapeutics

Job title: Chief Development Officer


SWOT Analysis Panel Discussion: 9:00 am

• What happened in the SKYSCRAPER trial? • Progress, momentum and advancements one year on • What are the strengths of existing TIGIT axis targeted therapies that continue to drive development? • What is the market opportunity versus unmet patient clinical need that TIGIT axis targeted approaches can address? • How can we overcome the…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.